Registration Graphic_Aug 28_top-01


Feature Sponsors



7:00 – 7:30 a.m.

 Breakfast: Presented by Dentons


7:45 – 9:00 a.m.

Fireside Chat: The Future of Clinical Research

Dr. Lawrence Richer in conversation with Marlon Rajakaruna, Dentons

Moderated  by Tom Sides, Dentons

Speaker Biographies

Tom is a partner and chair of the National Technology Transactions Law Group. His practice focuses extensively on technology, intellectual property, privacy and related commercial legal issues for clients in the energy, financial institution, health, forestry, information technology and
telecommunications industry sectors.

Tom has significant experience negotiating complex systems integration, software development, collaboration, research and development, joint venture, distribution, OEM, alliance, reseller and technology transfer agreements. His experience extends to leading or advising on merger and
acquisition transactions involving technology, IP and commercial legal issues.

In addition to technology and other industry sector clients that Tom has represented at Dentons, he has extensive legal and business experience in the software and telecommunications businesses. Tom’s unique combination of business and legal experience allows him to provide practical, business-focused legal advice to his clients.

Marlon is a partner and co-chair of Dentons’ Global Life Sciences and Healthcare groups, and has extensive experience in the life sciences, healthcare and technology areas. He acts for Canadian and foreign pharmaceutical companies, medical device companies, diagnostics companies, natural and non-prescription health product companies, dental practice management companies, hearing aid manufacturers, medical services companies, clinical research organizations, academic research organizations, academic health regions, universities, site management organizations, medical clinics, physicians, dentists and chiropractors.

Marlon is regularly involved in the negotiation of a variety of agreements, advising on risk management issues, regulatory matters, federal research funding requirements, contract enforcement and interpretation, developing various template agreements, guidelines and contract review procedures, drafting operating policies and procedures, providing strategic advice and helping develop organizational efficiencies, advising on the structuring of clinical trials, including multi-centre national and international clinical trials, and conducting training sessions on contract and risk management issues. He is a thought leader and highly sought-after speaker in the area of clinical research, and regularly speaks at national and international clinical research conferences.

Director, Northern Alberta Clinical Trials and Research Centre
Associate Dean, Clinical and Translational Research
Associate Director, Women and Children’s Health Research Institute
Associate Professor, Department of Pediatrics, Division of Neurology, University of Alberta
Pediatric Neurology, Stollery Children’s Hospital
9:10 – 11:40 a.m.

Companies in Health Bio-Pharma and Medical Device pitch to a panel and audience of investors. Companies have 10 minutes to pitch and five minute Q&A by panel and facilitator.

Moderated by:

Joanne Fedeyko, Founding member, Canadian Entrepreneur in Life Sciences (CELS)

Confirmed investors include:

  • Accel Rx
  • Acuris Partners
  • AFSC
  • AIMCo
  • Bloom Burton
  • Brass Dome Ventures
  • CDRD
  • Matthew Giannone – Angel investor
  • Merck – West Coast Innovation Hub
  • Peter Riddles – Angel investor
  • Quorum Health
  • Ramesh Rengarajan – Angel investor
  • RBC
  • Telus Ventures
  • VA Angels

Sponsored by


9:15 – 10:30 a.m.

Presented by:

Randy Thompson, Founder and Fund Manager, VA Angels

You don’t mean to lie when you approach your investors and claim, “this is all the money I am going to need.” The reality is, you’re wrong. This discussion will walk you through the funding model and break down your financial needs as a biotech company, including discussions on valuation, capital tables, dilution and distribution of returns.

10:40 – 11:40 a.m.

Presented by:

Hadi Salah, Industry Lead, Office of the Chief Health Innovation Strategist, Ontario Ministry of Health and Long Term Care


Dr. Ryan Comeau, CEO and Co-Founder, Kinetisense
Dr. Michael Guerriere, Chief Medical Officer, Vice President and Chief Strategy Officer, TELUS Health
Dr. Robert Hayward, Chief Medical Information Officer, Alberta Health Services
Dr. Lawrence Korngut, Associate Professor, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary; Director, Calgary ALS and Motor Neuron Disease Clinic
Hadi Salah, Manager, Health Ecosystem Partnerships, MaRS

Moderated by: Aggie Mikulski, Program Director, TEC Edmonton Health Accelerator

Sponsored by



12:00 p.m. – 1:45 p.m.

Sponsored by


Keynote: Innovation in Alberta’s Health System

with Dr. Verna Yiu, CEO, Alberta Health Services


Dr. Verna Yiu has served as CEO of Alberta Health Services (AHS) since 2016. Since being appointed in this role, Dr. Yiu has led the organization in the development of a new vision, refreshed values, and a health and business plan focused on four foundational strategies (patient first, people, research/innovation/analytics, and information management).

Dr. Yiu joined Alberta Health Services (AHS) in 20212 as Vice President, Quality and Chief Medical Officer. In this role, she oversaw the integration and coordination of a health delivery model for the province and was accountable for Quality & Health Care Improvement, Strategic Clinical Networks, Clinical Informatics and Clinical Information Systems, Medical Affairs, and partnerships with academic institutions and other physician-led organizations. The principal focus of her initial role within AHS was quality and patient safety, engagement, leadership development, and fostering relationships between medical staff and the health care system. Prior to joining AHS, Dr. Yiu served as interim Dean of the Faculty of Medicine and Dentistry at the University of Alberta, preceded by senior positions in the Dean’s office from 2000.

She is a graduate of the University of Alberta and Harvard University, and is currently a Professor of Pediatrics at the University of Alberta. She has also led various areas of health administration for more than 18 years, both within the health care delivery system and in academic settings. Dr. Yiu’s leadership roles have spanned heading clinical operations, leading medical education reforms and developing strong partnerships with academic institutions, government bodies, and other clinician-led organizations.

Panel Discussion & Round Tables

2:00 – 3:30 p.m.

 The focus will be to gather ideas for taking the next steps forward in advocacy for policy development.

Sponsored by

UC-research lockup-cmyk   RocheLogo_PMS300

The focus of this panel will be on the current status and opportunities that lie in access to health data. It will be structured in a panel discussion.


Karen Wichuk, Executive Lead, City of Edmonton Health City Initiative


  • Gandeephan Ganeshalingam, Chief Innovation Officer, GE Canada
  • Greg Horne, National Lead for Healthcare, SAS Canada
  • Dr. Christopher McCabe, Executive Director & CEO, Institute of Health Economics
  • Ronnie Miller, President & CEO, Roche Pharmaceuticals
  • Dr. Lawrence Richer, Director, Northern Alberta Clinical Trials and Research Centre
  • Dr. Kimberley Simmonds, Director, Health Evidence & Policy, Alberta Health

This discussion will focus on solutions to increasing industry development in natural health products and functional food. Dr. David Gauthier, Regional Director (West) Natural Products Canada, will deliver a 30 minute talk prior to the discussion.

Discussion items:

a) What is your vision for the Natural Health Products Sector in Alberta and what will it look like in 10 years?

b) What are the immediate challenges/barriers to success the industry faces and what actions should be taken (by whom) to resolve them?

c) What does the industry need to prepare itself for success in the global marketplace?

This discussion will focus on solutions for increasing industry development in Industrial Biotechnology.

Facilitated by:

Ross Bricker, Managaing Partner, Westcott Ventures

Discussion items:

a) What is your vision for the BioIndustrial sector in Alberta and what will it look like in 10 years?

b) What do you see as the major challenges barriers to success and what actions should be taken (by whom) to resolve them?

c) What does the industry need to prepare itself to be successful in the global marketplace?

Flash Pitches/Vendor Showcase/Networking

3:45 – 6:00 p.m.

Sponsored by

Tangent design engineering

3:45 – 5:00 p.m.

BioAlberta is providing you with an opportunity to speak to what you do. Any member of the life sciences community wishing to advertise a potential partnership or service has two minutes to describe themselves to the audience. What an ice breaker for an easier networking time in the reception to follow!

Contact Nicola McFarlane, Manager – Memberships and Partnerships for more details.

5:00 – 6:00 p.m.

Booth space

Immediately following the structured networking session is the BioAlberta Gala reception for casual networking. Those wishing to showcase their services or collaborations, will also be holding booth space around the reception.

Contact  Nicola McFarlane, Manager – Memberships and Partnerships for more details.

BioAlberta’s 18th Annual Awards Gala

6:00 – 9:00 p.m.


BioAlberta’s annual gala is held to network and celebrate outstanding achievements within the industry.  This premier event brings together the membership and friends of the industry to honour achievement and celebrate the industry’s milestones.

Opening remarks:

Honourable Deron Bilous, Minister of Economic Development and Trade

Keynote: We are on the brink of a revolution
with Shawn Kanungo, Senior Manager, Strategy, Deloitte

Single Ticket
Member: $210
Non-member: $250

Table (8)
Member: $1500
Non-member: $1800


Member: $300
Non-member: $325

Stay at the DoubleTree by Hilton at a discounted rate via the TEC Edmonton and BioAlberta booking link:


Registration is now closed.